Atuveciclib

CAT: 0804-HY-12871B-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-12871B-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Atuveciclib (BAY-1143572) is a potent and highly selective, oral PTEFb/CDK9 inhibitor. Atuveciclib (BAY-1143572) inhibits CDK9/CycT1 with an IC50 of 13 nM[1].
CAS Number
[2923012-24-0]
Product Name Alternative
BAY-1143572
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BAY-1143572.html
Purity
99.75
Solubility
DMSO : ≥ 128.5 mg/mL
Smiles
N=[S@](CC1=CC(NC2=NC(C3=CC=C(F)C=C3OC)=NC=N2)=CC=C1)(C)=O
Molecular Formula
C18H18FN5O2S
Molecular Weight
387.43
References & Citations
[1]Lücking U, et al. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer. ChemMedChem. 2017 Nov 8;12 (21) :1776-1793.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
CDK1; CDK2; CDK3; CDK5; CDK9

Alternative Products

CatalogName
MF-0004576-01Atuveciclib
MBS5752765Atuveciclib Racemate
MF-0004575(R) -Atuveciclib
MF-0004577-01Atuveciclib S-Enantiomer
C13621-01Atuveciclib (BAY-1143572)
A16810-2Atuveciclib (BAY-1143572) 2mg
A16810-25Atuveciclib (BAY-1143572) 25mg
A16810-10Atuveciclib (BAY-1143572) 10mg
A16810-5Atuveciclib (BAY-1143572) 5mg
A16810-100Atuveciclib (BAY-1143572) 100mg

Popular Products